文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血浆置换治疗脓毒症合并多器官衰竭的疗效:基于MIMIC-IV数据库的倾向性评分匹配分析

THE THERAPEUTIC EFFICACY OF PLASMAPHERESIS FOR SEPSIS WITH MULTIPLE ORGAN FAILURE: A PROPENSITY SCORE-MATCHED ANALYSIS BASED ON THE MIMIC-IV DATABASE.
PubMed 文献 · Shock · 2023-11-16
一句话结论在脓毒症合并多器官衰竭患者中,血浆置换与28天、住院及1年死亡风险降低相关(HR分别为0.50、0.38、0.44)。

本研究基于MIMIC-IV数据库纳入906例脓毒症合并多器官衰竭患者,经倾向性评分匹配后血浆置换组与常规治疗组各60例。血浆置换与28天死亡风险降低(HR 0.50,95%CI 0.27-0.94)、1年死亡风险降低(HR 0.44,95%CI 0.26-0.74)及住院死亡风险降低(HR 0.38,95%CI 0.20-0.71)相关。Kaplan-Meier曲线显示两组生存概率存在显著差异。血浆置换组较常规组随时间显著降低SOFA评分、去甲肾上腺素剂量、凝血酶原时间、乳酸脱氢酶、总胆红素、白细胞及未成熟粒细胞,同时随时间显著升高血小板、红细胞及血红蛋白。

要点

  • 脓毒症合并多器官衰竭患者中,血浆置换与28天死亡风险降低相关(HR 0.50;95%CI 0.27-0.94)。
  • 血浆置换与住院死亡风险降低(HR 0.38;95%CI 0.20-0.71)及1年死亡风险降低(HR 0.44;95%CI 0.26-0.74)相关。
  • 血浆置换组较常规组随时间显著降低SOFA评分、去甲肾上腺素剂量、凝血酶原时间、乳酸脱氢酶、总胆红素、白细胞及未成熟粒细胞。
  • 血浆置换组较常规组随时间显著升高血小板、红细胞及血红蛋白。
  • Kaplan-Meier曲线显示血浆置换组与常规组生存概率存在显著差异。

适用人群与场景

  • 从MIMIC-IV数据库中识别的脓毒症合并多器官衰竭患者,共纳入906例。
  • 经倾向性评分匹配后,血浆置换组与常规治疗组各60例。

研究设计与关键结果

  • 研究类型:基于MIMIC-IV数据库的倾向性评分匹配分析,纳入906例脓毒症合并多器官衰竭患者,匹配后血浆置换组与常规治疗组各60例。
  • 血浆置换与28天死亡风险降低相关(HR 0.50;95%CI 0.27-0.94)。
  • 血浆置换与1年死亡风险降低相关(HR 0.44;95%CI 0.26-0.74)。
  • 血浆置换与住院死亡风险降低相关(HR 0.38;95%CI 0.20-0.71)。
  • Kaplan-Meier曲线显示两组生存概率存在显著差异。
  • 血浆置换组较常规组随时间显著降低SOFA评分、去甲肾上腺素剂量、凝血酶原时间、乳酸脱氢酶、总胆红素、白细胞及未成熟粒细胞,随时间显著升高血小板、红细胞及血红蛋白。

证据类型、等级与局限

  • 证据类型:基于MIMIC-IV数据库的倾向性评分匹配分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在脓毒症合并多器官衰竭患者中,血浆置换可能与28天、住院及1年死亡风险降低相关。
  • 血浆置换可能通过改善器官功能、血流动力学及恢复凝血、贫血和炎症等指标来改善结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Despite advancements in sepsis treatment, mortality remains high. Plasmapheresis (PE) targeting multiple pathways simultaneously seems to be a potential treatment option, but evidence is insufficient. We aimed to investigate the efficacy of PE for sepsis with multiple organ failure (MOF). Method: Septic patients with MOF were identified from the Medical Information Mart for Intensive Care IV database. Patients who received PE were matched with those receiving conventional therapy via propensity score matching. Regression analyses evaluated the association between PE and outcomes. The Kaplan-Meier (KM) method was used to analyze the survival probability. The generalized additive mixed model investigated early indexes changes' association with treatment modalities and 28-day mortality. Results: Nine hundred six septic patients with MOF were enrolled. After propensity score matching, PE and conventional groups consisted of 60 cases each. Plasmapheresis was associated with a reduced risk of 28-day mortality (hazard ratio [HR], 0.50; 95% confidence interval [CI], 0.27-0.94), 1-year mortality (HR, 0.44; 95% CI, 0.26-0.74), and in-hospital mortality (HR, 0.38; 95% CI, 0.20-0.71). The KM curves demonstrated significant differences in survival probability between groups. Compared with the conventional group, the sequential organ failure assessment, norepinephrine dosage, prothrombin time, actate dehydrogenase, total bilirubin, white blood cells, and immature granulocytes in the PE group significantly decreased over time, while platelets, red blood cells, and hemoglobin significantly increased over time. Conclusions: Plasmapheresis demonstrated an association with reduced risks of 28-day, in-hospital and 1-year mortality in septic patients with MOF. Moreover, plasmapheresis might exhibit the potential to improve outcomes by improving organ function, hemodynamics, and restoring several indicators, such as coagulation, anemia, and inflammation.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Yan D, Yao R, Xie X, et al. THE THERAPEUTIC EFFICACY OF PLASMAPHERESIS FOR SEPSIS WITH MULTIPLE ORGAN FAILURE: A PROPENSITY SCORE-MATCHED ANALYSIS BASED ON THE MIMIC-IV DATABASE. Shock. 2023. PMID: 37988068. doi:10.1097/SHK.0000000000002254

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。